id: ghb_discontinuation_to_withdrawal_syndrome
name: GHB Discontinuation After Regular Use â†’ GHB Withdrawal Syndrome
from_node:
  node_id: ghb_discontinuation
  node_name: GHB Discontinuation After Regular Use
to_node:
  node_id: withdrawal_syndrome
  node_name: GHB Withdrawal Syndrome
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Regular GHB use creates neuroadaptation in central nervous system'
- 'Step 2: Abrupt discontinuation disrupts adapted neurotransmitter systems'
- 'Step 3: Withdrawal syndrome manifests with patterns similar to alcohol withdrawal'
- 'Step 4: Clinical presentation may be difficult to distinguish from other withdrawal
  syndromes, especially when toxicological testing is unavailable or negative'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'E. Marinelli et al. 2020. "Gamma-hydroxybutyrate Abuse: Pharmacology
    and Poisoning and Withdrawal Management." *Arhiv za Higijenu Rada i Toksikologiju*.
    https://doi.org/10.2478/aiht-2020-71-3314'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.697838'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: toxicological_test_availability
  direction: weakens
  strength: strong
  description: Unavailable or negative toxicological tests make GHB withdrawal difficult
    to distinguish from other withdrawal syndromes, potentially delaying appropriate
    treatment
